Scholarly Index
Antonio Bertoletti
Duke-NUS Medical School; 30,894 total citations; 375 total publications; best world rank #50
Duke-NUS Medical School
30,894Total citations
375Total publications
88H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 58 | SG 3 | 99.60 |
| Hepatitis B Virus Studies | Lifetime | 60 | SG 2 | 99.76 |
| Hepatitis C virus research | Lifetime | 96 | SG 1 | 99.65 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 135 | SG 4 | 99.36 |
| Immunotherapy and Immune Responses | Lifetime | 363 | SG 2 | 99.37 |
| Long-Term Effects of COVID-19 | Lifetime | 171 | SG 3 | 98.30 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 108 | SG 1 | 98.58 |
| Immune Cell Function and Interaction | Lifetime | 999 | SG 4 | 98.79 |
| Viral Infections and Outbreaks Research | Lifetime | 407 | SG 4 | 96.37 |
| Immune responses and vaccinations | Lifetime | 309 | SG 2 | 91.52 |
| vaccines and immunoinformatics approaches | Lifetime | 908 | SG 8 | 91.85 |
| COVID-19 Clinical Research Studies | 2021-2025 | 50 | SG 2 | 99.63 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 104 | SG 2 | 99.47 |
| Long-Term Effects of COVID-19 | 2021-2025 | 179 | SG 2 | 97.83 |
| Hepatitis B Virus Studies | 2021-2025 | 98 | SG 3 | 97.69 |
| Hepatitis C virus research | 2021-2025 | 522 | SG 5 | 92.29 |
| Viral Infections and Outbreaks Research | 2021-2025 | 461 | SG 3 | 86.26 |
| Immune responses and vaccinations | 2021-2025 | 627 | SG 4 | 64.05 |